Mannkind (MNKD) Inventory Average (2015 - 2026)
Mannkind (MNKD) reported Inventory Average of $42.2 million for Q1 2026, up 48.79% year-over-year from $28.4 million in Q1 2025, and up 35.63% quarter-over-quarter from $31.1 million in Q4 2025.
Mannkind (MNKD) Inventory Average (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has 12 years of Inventory Average data on file, last reported at $42.2 million in Q1 2026.
- Inventory Average for Q1 2026 came in at $42.2 million, up 48.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.2 million (up 48.79% YoY), and the FY2025 annual result was $31.6 million, up 11.99% from the prior year.
- Inventory Average advanced to $42.2 million in Q1 2026 per MNKD's latest filing, from $31.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $42.2 million in Q1 2026 and troughed at $7.6 million in Q1 2022.
- A 5-year average of $25.0 million and a median of $26.2 million in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average surged 188.04% in 2023, then dropped 2.0% in 2024.
- A 5-year view of Inventory Average shows it stood at $20.0 million in 2022, then jumped by 39.0% to $27.8 million in 2023, then decreased by 2.0% to $27.3 million in 2024, then increased by 14.18% to $31.1 million in 2025, then soared by 35.63% to $42.2 million in 2026.
- Business Quant data shows MNKD's Inventory Average at $42.2 million in Q1 2026, $31.1 million in Q4 2025, and $27.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | 42.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.24 Mn |
| Dec 31, 2025 | 31.14 Mn |
| Sep 30, 2025 | 27.73 Mn |
| Jun 30, 2025 | 28.69 Mn |
| Mar 31, 2025 | 28.39 Mn |
| Dec 31, 2024 | 27.27 Mn |
| Sep 30, 2024 | 25.71 Mn |
| Jun 30, 2024 | 25.60 Mn |
| Mar 31, 2024 | 27.49 Mn |
| Dec 31, 2023 | 27.83 Mn |
| Sep 30, 2023 | 26.20 Mn |
| Jun 30, 2023 | 23.64 Mn |
| Mar 31, 2023 | 21.89 Mn |
| Dec 31, 2022 | 20.02 Mn |
| Sep 30, 2022 | 19.42 Mn |
| Jun 30, 2022 | 14.31 Mn |
| Mar 31, 2022 | 7.60 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | 7.48 Mn |
| Jun 30, 2021 | 6.27 Mn |